Ranalexin

General Information


DCTPep ID  DCTPep00447

Peptide Name   Ranalexin

Sequence  FLGGLIKIVPAMICAVTKKC

Sequence Length  20

UniProt ID  P39084 

PubChem CID  Not available

Origin  Rana catesbeiana

Type  Native peptide

Classification

  

ACP Tumor active peptide Membrane-targeted



Activity Information


Cell Line Disease Activity Assay Testing Time Literature
HeLa Human papillomavirus-related endocervical adenocarcinoma IC50=13.4 µg/ml MTT assay 24h 1
LNCaP C4-2 Prostate carcinoma IC50=30 µg/ml MTT assay 24 h 2
MEC-7 Invasive breast carcinoma of no special type IC50=30 µg/ml MTT assay 24 h 2
HepG2 Hepatoblastoma IC50=31 µg/ml MTT assay 24 h 2

Hemolytic Activity  Human erythrocytes: <15% Hemolysis=250 µg/ml

Normal (non-cancerous) Cytotoxicity  Monkey COS-7: IC50=14.8 µg/ml; NL20: Not active up to 62.5 µg/ml

Target  Not available

Affinity  Not available

Mechanism  Not available



Structure Information


PDB ID  Not available

Predicted Structure  DCTPep00447

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Cys14<--->Cys20

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C97H169N23O22S3

Absent amino acids  DEHNQRSWY

Theoretical pI  9.39

Acidic residues  0

Basic residues  3

Polar residues  5

Molecular weight (Average)  2105.73

Molecular weight (Monoisotopic)  2104.2

Common amino acids  IK

Net charge  3

Instability index (II)  17.95

Aliphatic index  136.50

Grand average of hydropathicity (GRAVY)  1.400

Half Life 
  1.1 hours (mammalian reticulocytes, in vitro).
  3 min (yeast, in vivo).
  2 min (Escherichia coli, in vivo).

Extinction coefficients 
  Ext. coefficient 125
  Abs 0.1% (=1 g/l) 0.059, assuming all pairs of Cys residues form cystines
  Ext. coefficient 0
  Abs 0.1% (=1 g/l) 0.000, assuming all Cys residues are reduced

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23053091

Title  Molecular cloning and expression of ranalexin, a bioactive antimicrobial peptide from Rana catesbeiana in Escherichia coli and assessments of its biological activities

Doi 10.1007/s00253-012-4441-1

Year  2013

Literature 2

Pubmed ID 29649587

Title  A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics

Doi 10.1016/j.ijantimicag.2018.03.023

Year  2018

Literature 3

Pubmed ID 26046345

Title  Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae

Doi 10.1371/journal.pone.0128532

Year  2015

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DCTPep is developed by Dr.Zheng's team.